Abstract: A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier demonstrates therapeutic efficacy in treating lesions including cancerous lesions, precancerous lesions, cysts and warts.
Type:
Grant
Filed:
May 16, 2006
Date of Patent:
September 6, 2011
Assignee:
Dermex Pharmaceuticals, LLC
Inventors:
Russel T. Jordan, Carl C. Hanson, Frank S. Potestio
Abstract: Oxinates including 8-hydroxyquinoline and a heavy metal are topically applied to epidermal lesions for therapeutic effect. The zinc oxinate compositions are shown to be therapeutically effective against The therapeutic composition demonstrates selective toxicity with a therapeutic index of one-hundred percent on human lung cancer, breast cancer, melanoma, venereal warts, male veruoca warts, lesions produced by human papilloma virus, basal cell carcinoma, solar keratosis, and Kaposi's sarcoma. In veterinary applications where dogs, cats, and horses are the patients, the composition shows a one-hundred percent therapeutic index with selective toxicity against eye cancer, sarcoids, sarcoma, malignant melanoma, rectal adenoma, histiocytoma, and sebaceous adenoma.
Type:
Grant
Filed:
February 10, 1998
Date of Patent:
December 7, 2010
Assignee:
Dermex Pharmaceuticals, LLC
Inventors:
Russel T. Jordan, Carl C. Hanson, Frank S. Potestio
Abstract: A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier demonstrates therapeutic efficacy in treating lesions including cancerous lesions, precancerous lesions, cysts and warts.
Type:
Grant
Filed:
September 18, 2002
Date of Patent:
June 13, 2006
Assignee:
Dermex Pharmaceuticals, LLC
Inventors:
Russel T. Jordan, Carl C. Hanson, Frank S. Potestio
Abstract: A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier is effective in treating the bite of the brown recluse spider.
Type:
Grant
Filed:
September 18, 2002
Date of Patent:
August 10, 2004
Assignee:
Dermex Pharmaceuticals, LLC
Inventors:
Russel T. Jordan, Carl C. Hanson, Frank S. Potestio
Abstract: Oxinates including 8-hydroxyquinoline and a heavy metal are topically applied to epidermal lesions for therapeutic effect, wherein said epithelial lesions selected from the croup consisting of cancerous lesions, precancerous lesions, cysts and warts; and permitting said composition to destroy said lesion.
Type:
Grant
Filed:
January 2, 2001
Date of Patent:
November 5, 2002
Assignee:
Dermex Pharmaceuticals, LLC
Inventors:
Russel T. Jordan, Carl C. Hanson, Frank S. Potestio